• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受骨髓移植治疗的重症联合免疫缺陷患者的长期随访

Long-term follow-up in patients with severe combined immunodeficiency treated by bone marrow transplantation.

作者信息

Friedrich Wilhelm, Hönig Manfred, Müller Susanna M

机构信息

Department of Pediatrics, University of Ulm, Ulm, Germany.

出版信息

Immunol Res. 2007;38(1-3):165-73. doi: 10.1007/s12026-007-0030-2.

DOI:10.1007/s12026-007-0030-2
PMID:17917023
Abstract

Immune reconstitution was studied in 31 long-term surviving patients after bone marrow transplantation for severe combined immunodeficiency. Donors in 7 cases were HLA-identical and in 25 cases HLA-haploidentical family members, and in 13 of these latter cases cytoreductive conditioning had been used prior to transplantation. At a mean follow-up of 15 years after transplantation (range 10 to 22 years), T cell numbers and functions had remained stable and within normal limits in the majority of patients. Marked variability however was observed with regard to reconstitution of B cell immunity. Furthermore numbers of circulating naïve CD4+ T cells were variable and markedly diminished in a substantial proportion of patients at recent evaluations. Normal B cell immunity and persistently normal naïve T cell numbers were strongly correlated with the continued detection of donor type CD34+ precursor cells in the patients marrow, which were absent in non conditioned patients. These findings indicate that stable donor precursor cell engraftment in the marrow may be of relevance for complete and stable long-term immune reconstitution in transplanted SCID patients.

摘要

对31例接受骨髓移植治疗严重联合免疫缺陷的长期存活患者的免疫重建情况进行了研究。7例供者为HLA全相合,25例为HLA单倍体相合家庭成员,其中13例在移植前使用了细胞减灭预处理。移植后平均随访15年(范围10至22年),大多数患者的T细胞数量和功能保持稳定且在正常范围内。然而,在B细胞免疫重建方面观察到明显的变异性。此外,在最近的评估中,循环中初始CD4+ T细胞数量可变,且在相当一部分患者中显著减少。正常的B细胞免疫和持续正常的初始T细胞数量与在患者骨髓中持续检测到供者型CD34+前体细胞密切相关,未进行预处理的患者中不存在这些细胞。这些发现表明,骨髓中稳定的供者前体细胞植入可能与移植的重症联合免疫缺陷患者的完全和稳定的长期免疫重建相关。

相似文献

1
Long-term follow-up in patients with severe combined immunodeficiency treated by bone marrow transplantation.接受骨髓移植治疗的重症联合免疫缺陷患者的长期随访
Immunol Res. 2007;38(1-3):165-73. doi: 10.1007/s12026-007-0030-2.
2
Role of reduced intensity conditioning in T-cell and B-cell immune reconstitution after HLA-identical bone marrow transplantation in ADA-SCID.ADA-SCID 患者 HLA 相合同种异体骨髓移植后,低强度调理在 T 细胞和 B 细胞免疫重建中的作用。
Haematologica. 2010 Oct;95(10):1778-82. doi: 10.3324/haematol.2010.025098. Epub 2010 May 11.
3
Transplantation of X-linked severe combined immunodeficient dogs with CD34+ bone marrow cells.用CD34 +骨髓细胞对X连锁重症联合免疫缺陷犬进行移植。
Biol Blood Marrow Transplant. 2002;8(4):188-97. doi: 10.1053/bbmt.2002.v8.pm12014808.
4
Relationship between patterns of engraftment in peripheral blood and immune reconstitution after allogeneic bone marrow transplantation for (severe) combined immunodeficiency.异基因骨髓移植治疗(重症)联合免疫缺陷后外周血植入模式与免疫重建的关系。
Blood. 1994 Dec 1;84(11):3936-47.
5
Long-term immune reconstitution and outcome after HLA-nonidentical T-cell-depleted bone marrow transplantation for severe combined immunodeficiency: a European retrospective study of 116 patients.严重联合免疫缺陷患者接受 HLA 不匹配且去除 T 细胞的骨髓移植后的长期免疫重建及预后:一项针对 116 例患者的欧洲回顾性研究
Blood. 1998 May 15;91(10):3646-53.
6
Evidence for engraftment of donor-type multipotent CD34+ cells in a patient with selective T-lymphocyte reconstitution after bone marrow transplantation for B-SCID.骨髓移植治疗重症联合免疫缺陷病(B-SCID)后选择性T淋巴细胞重建患者中供体来源多能CD34+细胞植入的证据。
Blood. 1994 Nov 15;84(10):3584-9.
7
Circulating red cells usually remain of host origin after bone marrow transplantation for severe combined immunodeficiency.在因重症联合免疫缺陷而进行骨髓移植后,循环红细胞通常仍来源于宿主。
Transfusion. 1996 Apr;36(4):314-7. doi: 10.1046/j.1537-2995.1996.36496226143.x.
8
Full immunologic reconstitution following nonconditioned bone marrow transplantation for canine X-linked severe combined immunodeficiency.犬X连锁严重联合免疫缺陷非预处理骨髓移植后的完全免疫重建。
Blood. 1997 Oct 15;90(8):3214-21.
9
Bone marrow 'boosts' following T cell-depleted haploidentical bone marrow transplantation.T细胞去除的单倍体相合骨髓移植后的骨髓“增强”
Bone Marrow Transplant. 1996 Apr;17(4):543-8.
10
Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency.造血干细胞移植治疗重症联合免疫缺陷病。
N Engl J Med. 1999 Feb 18;340(7):508-16. doi: 10.1056/NEJM199902183400703.

引用本文的文献

1
SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery.SCID 基因型和移植后 6 个月的 CD4 计数可预测生存和免疫恢复情况。
Blood. 2018 Oct 25;132(17):1737-1749. doi: 10.1182/blood-2018-03-840702. Epub 2018 Aug 28.
2
Longitudinal Evaluation of Immune Reconstitution and B-cell Function After Hematopoietic Cell Transplantation for Primary Immunodeficiency.原发性免疫缺陷症造血细胞移植后免疫重建和 B 细胞功能的纵向评估。
J Clin Immunol. 2015 May;35(4):373-83. doi: 10.1007/s10875-015-0154-4. Epub 2015 Apr 15.
3
Hematopoietic stem cell transplantation for primary immunodeficiencies.

本文引用的文献

1
Bone marrow transplantation for severe combined immune deficiency.用于重症联合免疫缺陷的骨髓移植
JAMA. 2006 Feb 1;295(5):508-18. doi: 10.1001/jama.295.5.508.
2
Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99.造血干细胞长期存活及移植治疗免疫缺陷:欧洲1968 - 1999年经验报告
Lancet. 2003 Feb 15;361(9357):553-60. doi: 10.1016/s0140-6736(03)12513-5.
3
Similar pattern of thymic-dependent T-cell reconstitution in infants with severe combined immunodeficiency after human leukocyte antigen (HLA)-identical and HLA-nonidentical stem cell transplantation.
原发性免疫缺陷的造血干细胞移植
Hematol Oncol Clin North Am. 2014 Dec;28(6):1157-70. doi: 10.1016/j.hoc.2014.08.006. Epub 2014 Sep 16.
4
SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID.ARTEMIS 与 RAG 缺陷的 SCID 患者在 HCT 后:ARTEMIS 缺陷的 SCID 中晚期毒性风险增加。
Blood. 2014 Jan 9;123(2):281-9. doi: 10.1182/blood-2013-01-476432. Epub 2013 Oct 21.
5
B-cell reconstitution for SCID: should a conditioning regimen be used in SCID treatment?B 细胞重建用于 SCID:SCID 治疗中是否应使用预处理方案?
J Allergy Clin Immunol. 2013 Apr;131(4):994-1000. doi: 10.1016/j.jaci.2013.01.047. Epub 2013 Mar 5.
6
Effects of conditioning regimens and T cell depletion in hematopoietic cell transplantation for primary immune deficiency.原发性免疫缺陷症的造血细胞移植中预处理方案和 T 细胞耗竭的作用。
Biol Blood Marrow Transplant. 2012 Dec;18(12):1911-20. doi: 10.1016/j.bbmt.2012.07.014. Epub 2012 Jul 27.
7
IL-21 is the primary common γ chain-binding cytokine required for human B-cell differentiation in vivo.IL-21 是体内人 B 细胞分化所必需的主要共同γ链结合细胞因子。
Blood. 2011 Dec 22;118(26):6824-35. doi: 10.1182/blood-2011-06-362533. Epub 2011 Oct 28.
8
Genotype, phenotype, and outcomes of nine patients with T-B+NK+ SCID.9例T⁻B⁺NK⁺重症联合免疫缺陷患者的基因型、表型及预后
Pediatr Transplant. 2011 Nov;15(7):733-41. doi: 10.1111/j.1399-3046.2011.01563.x. Epub 2011 Aug 23.
9
Transplantation of hematopoietic stem cells in human severe combined immunodeficiency: longterm outcomes.造血干细胞移植治疗人类严重联合免疫缺陷:长期结果。
Immunol Res. 2011 Apr;49(1-3):25-43. doi: 10.1007/s12026-010-8191-9.
10
B-cell function in severe combined immunodeficiency after stem cell or gene therapy: a review.B 细胞功能在干细胞或基因治疗后的严重联合免疫缺陷:综述。
J Allergy Clin Immunol. 2010 Apr;125(4):790-7. doi: 10.1016/j.jaci.2010.02.012.
在人类白细胞抗原(HLA)匹配和不匹配的干细胞移植后,重症联合免疫缺陷婴儿中胸腺依赖性T细胞重建的相似模式。
Blood. 2000 Dec 15;96(13):4344-9.
4
Thymic function after hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency.造血干细胞移植治疗重症联合免疫缺陷后的胸腺功能
N Engl J Med. 2000 May 4;342(18):1325-32. doi: 10.1056/NEJM200005043421804.
5
Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency.造血干细胞移植治疗重症联合免疫缺陷病。
N Engl J Med. 1999 Feb 18;340(7):508-16. doi: 10.1056/NEJM199902183400703.
6
Transplantation for severe combined immunodeficiency with HLA-A,B,D,DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells.采用大豆凝集素和绵羊红细胞对与 HLA - A、B、D、DR 不相容的亲代骨髓细胞进行分离后,用于重症联合免疫缺陷的移植。
Blood. 1983 Feb;61(2):341-8.
7
Immunological reconstitution of sex-linked lymphopenic immunological deficiency.性连锁淋巴细胞减少性免疫缺陷的免疫重建
Lancet. 1968 Dec 28;2(7583):1366-9. doi: 10.1016/s0140-6736(68)92673-1.
8
The bulk of the peripheral B-cell pool in mice is stable and not rapidly renewed from the bone marrow.小鼠外周B细胞库的大部分是稳定的,不会迅速从骨髓中更新。
Proc Natl Acad Sci U S A. 1990 Jun;87(12):4781-4. doi: 10.1073/pnas.87.12.4781.
9
European experience of bone-marrow transplantation for severe combined immunodeficiency.欧洲严重联合免疫缺陷病骨髓移植的经验
Lancet. 1990 Oct 6;336(8719):850-4. doi: 10.1016/0140-6736(90)92348-l.
10
Thymus-grafted SCID mice show transient thymopoiesis and limited depletion of V beta 11+ T cells.胸腺移植的重症联合免疫缺陷(SCID)小鼠表现出短暂的胸腺生成和Vβ11 + T细胞的有限耗竭。
J Exp Med. 1992 Apr 1;175(4):1067-71. doi: 10.1084/jem.175.4.1067.